FULCRUM THERAPEUTICS, INC. (FULC) Net income 2018–2025
FULCRUM THERAPEUTICS, INC. (FULC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$74.9MFY2025 · since FY2018: -$32.6M → -$74.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$74.9M | -670.0% |
| FY2024 | -$9.7M | +90.0% |
| FY2023 | -$97.3M | +11.4% |
| FY2022 | -$109.9M | -35.9% |
| FY2021 | -$80.8M | -14.2% |
| FY2020 | -$70.8M | +14.3% |
| FY2019 | -$82.7M | -153.7% |
| FY2018 | -$32.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FULC financial trends
FULC RevenueFULC Net marginFULC Gross profitFULC Gross marginFULC Operating incomeFULC Operating marginFULC Operating cash flowFULC Free cash flowFULC Capital expendituresFULC Return on equityFULC Stock buybacksFULC Dividends paidFULC Total assetsFULC Total liabilitiesFULC Shareholders’ equityFULC overview →